Europe Pharmaceutical Cold Chain Logistics Market By Product, Temperature Type and Mode of Transportation : Country Opportunity Analysis and Industry Forecast, 2023 - 2032

Europe Pharmaceutical Cold Chain Logistics Market By Product, Temperature Type and Mode of Transportation : Country Opportunity Analysis and Industry Forecast, 2023 - 2032


Reseller Report Description

A cold chain is a fundamental part of pharma shipments and transits. It is often considered a temperature-controlled supply system used to store and transport perishable products, such as vaccines, biologics, and drugs. This chain must preserve a particular temperature range, often between 2°C and 8°C, to preserve the safety, potency, and efficacy of pharmaceutical products through the entire supply chain, from manufacturing and storage to transportation and distribution. Aside from directing processes, manufacturers, distributors, and healthcare providers benefit from technological innovations and developments to preserve the quality and integrity of pharmaceutical products and, consequently, ensure the safety of the consumers in need.

The integration of radiofrequency identification technology (RFID), AI, and blockchain technology in pharmaceutical cold-chain logistics is expected to revolutionize the cold-chain logistics industry, making it more efficient and secure. RFID system for cold chain applications consists of a reader, a tag, and a sensor that communicate with one another via radio transmission. If they have the right sensor and enough power, RFID tags can store a finite number of temperature measurements in addition to an electronic product code (EPC) for logistics management purposes.

In addition, RFID technologies improve the performance of perishable supply chains through the device to track the geographical position of individual packages, pallets, shipping containers, or trucks, which can be stationary or in movement during distribution. These technologies are used to identify items through a unique EPC or other barcode and to store real-time environmental data (including temperature), which is later transmitted, allowing corrective actions to be taken before products are irrevocably damaged. The technology provides manufacturers the transparency in tracing and protecting throughout the product supply chain.

Rise in several refrigerated warehouses and expansion of the pharmaceutical sector, along with the government policies and initiatives to promote cold chain logistics is expected to drive the growth of the pharmaceutical cold chain logistics market. In addition, the constant development of machines and medicines due to the rising number of approvals for pharmaceutical products in Europe fuels the growth of the aftermarket shock absorbers market. On the contrary, the rise in the number of products and services, from vaccines to cell and gene therapies, requires cold chain handling and refrigerated warehouses are projected to offer lucrative opportunities for the expansion of the market during the forecast period.

However, there is a concern about the high cost required for maintaining cold chain logistics, such as refrigerated storage facilities and transportation systems that poses a considerable challenge to the growth of the market. This cost can act as a barrier for smaller pharmaceutical companies or those operating in developing regions. Further, temperature excursions or disruptions in the cold chain may result in the loss of valuable pharmaceutical products. This risk is especially significant for temperature-sensitive medications, vaccines, and biologics, leading to financial losses and potential reputational damage for pharmaceutical companies. This is expected to hamper the growth of Europe's pharmaceutical cold chain logistics market.

The Europe pharmaceutical cold chain logistics market is segmented into product, temperature type, mode of transportation, and region. By product, the market is divided into vaccines, biologics, specialty medications, and others. On the basis of temperature type, it is bifurcated into chilled, frozen, and room temperature. Depending on the mode of transportation, it is categorized into railways, airways, roadways, and waterways. Country-wise, the market is analyzed across France, Germany, Italy, Spain, the UK, Switzerland, Ireland, and the rest of Europe.

Key players covered in the report include A.P. Moller–Maersk, DB Schenker, DHL Group, DSV, Geodis, H. Essers, Kuehne + Nagel, Movianto, Sovereign, and VTS Transport & Logistics. These companies have adopted strategies such as product launches, product development, and others to improve their market positioning.

Please Note: It will take 7-10 business days to complete the report upon order confirmation.


CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in number of refrigerated warehouses and expansion of the pharmaceutical sector
3.4.1.2. Government policies and initiatives to promote the cold chain logistics in the pharmaceutical sector
3.4.2. Restraints
3.4.2.1. Poor infrastructure and higher logistics costs
3.4.2.2. Environmental concerns regarding greenhouse gas emission
3.4.3. Opportunities
3.4.3.1. Surge in use of IT solutions & automated software for pharmaceutical cold chain logistics
3.4.3.2. Rise in demand for temperature-sensitive pharmaceutical drugs
3.5. COVID-19 Impact Analysis
3.6. Active Vs Passive Cold Chain Transportation
3.7. Importance of Active Vs Passive Cold Chain Transportation
3.7.1. Global Pharmaceutical Cold Chain Logistics Market, by Region, 2022-2032 ($Million)
3.8. Market Size and Forecast for Parcels, by Type, 2022-2032 ($Million)
3.9. Market Size and Forecast for Pallets, by Type, 2022-2032 ($Million)
CHAPTER 4: EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT
4.1. Overview
4.2. Vaccines
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by country
4.3. Biologics
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by country
4.4. Specialty medications
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by country
4.5. Others
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by country
CHAPTER 5: EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE
5.1. Overview
5.2. Chilled
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by country
5.3. Frozen
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by country
5.4. Room Temperature (15-25°C)
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by country
CHAPTER 6: EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION
6.1. Overview
6.2. Railways
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country
6.3. Airways
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.4. Roadways
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by type
6.4.3. Market size and forecast, by region
6.5. Waterways
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by region
CHAPTER 7: EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY COUNTRY
7.1. Overview
7.2. Europe
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. France
7.2.2.1.1. Market size and forecast, by Product
7.2.2.1.2. Market size and forecast, by Temperature Type
7.2.2.1.3. Market size and forecast, by Mode of Transportation
7.2.2.2. Germany
7.2.2.2.1. Market size and forecast, by Product
7.2.2.2.2. Market size and forecast, by Temperature Type
7.2.2.2.3. Market size and forecast, by Mode of Transportation
7.2.2.3. Italy
7.2.2.3.1. Market size and forecast, by Product
7.2.2.3.2. Market size and forecast, by Temperature Type
7.2.2.3.3. Market size and forecast, by Mode of Transportation
7.2.2.4. Spain
7.2.2.4.1. Market size and forecast, by Product
7.2.2.4.2. Market size and forecast, by Temperature Type
7.2.2.4.3. Market size and forecast, by Mode of Transportation
7.2.2.5. UK
7.2.2.5.1. Market size and forecast, by Product
7.2.2.5.2. Market size and forecast, by Temperature Type
7.2.2.5.3. Market size and forecast, by Mode of Transportation
7.2.2.6. Switzerland
7.2.2.6.1. Market size and forecast, by Product
7.2.2.6.2. Market size and forecast, by Temperature Type
7.2.2.6.3. Market size and forecast, by Mode of Transportation
7.2.2.7. Ireland
7.2.2.7.1. Market size and forecast, by Product
7.2.2.7.2. Market size and forecast, by Temperature Type
7.2.2.7.3. Market size and forecast, by Mode of Transportation
7.2.2.8. Rest of Europe
7.2.2.8.1. Market size and forecast, by Product
7.2.2.8.2. Market size and forecast, by Temperature Type
7.2.2.8.3. Market size and forecast, by Mode of Transportation
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Key player positioning ,2022
8.2. Competitive dashboard
8.2.1. Top winning strategies
CHAPTER 9: COMPANY PROFILES
9.1. A.P. MOLLER MAERSK
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. DB SCHENKER
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. DHL GROUP
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. DSV
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. GEODIS
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. H. ESSERS
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Key strategic moves and developments
9.7. KUEHNE + NAGEL
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. MOVIANTO
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. SOVEREIGN
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Key strategic moves and developments
9.10. VTS TRANSPORT & LOGISTICS
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
List of Tables
TABLE 01. GLOBAL PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 02. MARKET SIZE AND FORECAST FOR PARCELS, BY TYPE, 2022-2032 ($MILLION)
TABLE 03. MARKET SIZE AND FORECAST FOR PALLETS, BY TYPE, 2022-2032 ($MILLION)
TABLE 04. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 05. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR VACCINES, BY COUNTRY,
2022–2032 ($MILLION)
TABLE 06. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR BIOLOGICS, BY COUNTRY,
2022–2032 ($MILLION)
TABLE 07. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR SPECIALTY MEDICATIONS,
BY COUNTRY, 2022–2032 ($MILLION)
TABLE 08. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR OTHERS, BY COUNTRY,
2022–2032 ($MILLION)
TABLE 09. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE, 2022-2032 ($MILLION)
TABLE 10. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR CHILLED, BY COUNTRY, 2022–2032 ($MILLION)
TABLE 11. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR FROZEN, BY COUNTRY,
2022–2032 ($MILLION)
TABLE 12. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR ROOM TEMPERATURE,
BY COUNTRY, 2022–2032 ($MILLION)
TABLE 13. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION, 2022-2032 ($MILLION)
TABLE 14. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR RAILWAYS, BY COUNTRY, 2022–2032 ($MILLION)
TABLE 15. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR AIRWAYS, BY REGION, 2022–2032 ($MILLION)
TABLE 16. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR ROADWAYS, BY TYPE, 2022–2032 ($MILLION)
TABLE 17. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR ROADWAYS, BY REGION, 2022–2032 ($MILLION)
TABLE 18. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET FOR WATERWAYS, BY REGION, 2022–2032 ($MILLION)
TABLE 19. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. FRANCE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 21. FRANCE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE, 2022-2032 ($MILLION)
TABLE 22. FRANCE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION, 2022-2032 ($MILLION)
TABLE 23. GERMANY PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 24. GERMANY PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE,
2022-2032 ($MILLION)
TABLE 25. GERMANY PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION, 2022-2032 ($MILLION)
TABLE 26. ITALY PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 27. ITALY PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE, 2022-2032 ($MILLION)
TABLE 28. ITALY PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION,
2022-2032 ($MILLION)
TABLE 29. SPAIN PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 30. SPAIN PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE, 2022-2032 ($MILLION)
TABLE 31. SPAIN PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION,
2022-2032 ($MILLION)
TABLE 32. UK PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 33. UK PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE, 2022-2032 ($MILLION)
TABLE 34. UK PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION,
2022-2032 ($MILLION)
TABLE 35. SWITZERLAND PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 36. SWITZERLAND PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE,
2022-2032 ($MILLION)
TABLE 37. SWITZERLAND PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION, 2022-2032 ($MILLION)
TABLE 38. IRELAND PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 39. IRELAND PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE, 2022-2032 ($MILLION)
TABLE 40. IRELAND PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION, 2022-2032 ($MILLION)
TABLE 41. REST OF EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 42. REST OF EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE, 2022-2032 ($MILLION)
TABLE 43. REST OF EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION, 2022-2032 ($MILLION)
TABLE 44. A.P. MOLLER-MAERSK: KEY EXECUTIVES
TABLE 45. A.P. MOLLER-MAERSK: COMPANY SNAPSHOT
TABLE 46. A.P. MOLLER-MAERSK: OPERATING SEGMENTS
TABLE 47. A.P. MOLLER-MAERSK: PRODUCT PORTFOLIO
TABLE 48. A.P. MOLLER-MAERSK: NET SALES, 2020-2022 ($MILLION)
TABLE 49. A.P. MOLLER-MAERSK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 50. DB SCHENKER: KEY EXECUTIVES
TABLE 51. DB SCHENKER: COMPANY SNAPSHOT
TABLE 52. DB SCHENKER: OPERATING SEGMENTS
TABLE 53. DB SCHENKER: PRODUCT PORTFOLIO
TABLE 54. DB SCHENKER: NET SALES, 2020-2022 ($MILLION)
TABLE 55. DB SCHENKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 56. DHL GROUP: KEY EXECUTIVES
TABLE 57. DHL GROUP: COMPANY SNAPSHOT
TABLE 58. DHL GROUP: OPERATING SEGMENTS
TABLE 59. DHL GROUP: PRODUCT PORTFOLIO
TABLE 60. DHL GROUP: NET SALES, 2020-2022 ($MILLION)
TABLE 61. DHL GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 62. DSV: KEY EXECUTIVES
TABLE 63. DSV: COMPANY SNAPSHOT
TABLE 64. DSV: OPERATING SEGMENTS
TABLE 65. DSV: PRODUCT PORTFOLIO
TABLE 66. DSV: NET SALES, 2020-2022 ($MILLION)
TABLE 67. DSV: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 68. GEODIS: KEY EXECUTIVES
TABLE 69. GEODIS: COMPANY SNAPSHOT
TABLE 70. GEODIS: OPERATING SEGMENTS
TABLE 71. GEODIS: PRODUCT PORTFOLIO
TABLE 72. GEODIS: NET SALES, 2020-2022 ($MILLION)
TABLE 73. KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 74. H. ESSERS: KEY EXECUTIVES
TABLE 75. H. ESSERS: COMPANY SNAPSHOT
TABLE 76. H. ESSERS: OPERATING SEGMENTS
TABLE 77. H. ESSERS: PRODUCT PORTFOLIO
TABLE 78. H. ESSERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79. KUEHNE+NAGEL: KEY EXECUTIVES
TABLE 80. KUEHNE+NAGEL: COMPANY SNAPSHOT
TABLE 81. KUEHNE+NAGEL: OPERATING SEGMENTS
TABLE 82. KUEHNE+NAGEL: PRODUCT PORTFOLIO
TABLE 83. KUEHNE+NAGEL: NET SALES, 2020–2022 ($MILLION)
TABLE 84. MOVIANTO: KEY EXECUTIVES
TABLE 85. MOVIANTO: COMPANY SNAPSHOT
TABLE 86. MOVIANTO: OPERATING SEGMENTS
TABLE 87. MOVIANTO: PRODUCT PORTFOLIO
TABLE 88. SOVEREIGN: KEY EXECUTIVES
TABLE 89. SOVEREIGN: COMPANY SNAPSHOT
TABLE 90. SOVEREIGN: OPERATING SEGMENTS
TABLE 91. SOVEREIGN: PRODUCT PORTFOLIO
TABLE 92. SOVEREIGN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 93. VTS TRANSPORT & LOGISTICS: KEY EXECUTIVES
TABLE 94. VTS TRANSPORT & LOGISTICS: COMPANY SNAPSHOT
TABLE 95. VTS TRANSPORT & LOGISTICS: OPERATING SEGMENTS
TABLE 96. VTS TRANSPORT & LOGISTICS: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. EXECUTIVE SUMMARY
FIGURE 03. TOP IMPACTING FACTORS (2022 & 2032)
FIGURE 04. TOP INVESTMENT POCKETS, 2022
FIGURE 05. MODERATE-TO-HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. LOW-TO-HIGH INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. ACTIVE VS PASSIVE COLD CHAIN TRANSPORTATION, 2022
FIGURE 11. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY PRODUCT, 2022–2032 ($MILLION)
FIGURE 12. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY TEMPERATURE TYPE, 2022–2032 ($MILLION)
FIGURE 13. EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, BY MODE OF TRANSPORTATION, 2022–2032 ($MILLION)
FIGURE 14. FRANCE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, 2022-2032 ($MILLION)
FIGURE 15. GERMANY PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, 2022-2032 ($MILLION)
FIGURE 16. ITALY PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, 2022-2032 ($MILLION)
FIGURE 17. SPAIN PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, 2022-2032 ($MILLION)
FIGURE 18. UK PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, 2022-2032 ($MILLION)
FIGURE 19. SWITZERLAND PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, 2022-2032 ($MILLION)
FIGURE 20. IRELAND PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, 2022-2032 ($MILLION)
FIGURE 21. REST OF EUROPE PHARMACEUTICAL COLD CHAIN LOGISTICS MARKET, 2022-2032 ($MILLION)
FIGURE 22. KEY PLAYER POSITIONING ,2022
FIGURE 23. COMPETITIVE DASHBOARD
FIGURE 24. COMPETITIVE DASHBOARD
FIGURE 25. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 29. A.P. MOLLER-MAERSK: NET SALES, 2020-2022 ($MILLION)
FIGURE 30. A.P. MOLLER-MAERSK: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 31. A.P. MOLLER-MAERSK: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 32. DEUTSCHE POST AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 33. DB SCHENKER: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 34. DB SCHENKER: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 35. DHL GROUP: NET SALES, 2020-2022 ($MILLION)
FIGURE 36. DHL GROUP: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 37. DHL GROUP: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 38. DSV: NET SALES, 2020-2022 ($MILLION)
FIGURE 39. DSV: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 40. DSV: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 41. GEODIS: NET SALES, 2020-2022 ($MILLION)
FIGURE 42. KUEHNE+NAGEL: NET SALES, 2020–2022 ($MILLION)
FIGURE 43. KUEHNE+NAGEL: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 44. KUEHNE+NAGEL: REVENUE SHARE BY REGION, 2022 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings